We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant

Delisted

CYTXW was delisted on the 14th of December, 2018.

2 hedge funds and large institutions have $1K invested in Cytori Therapeutics Inc Warrant in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 42 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

91% less capital invested

Capital invested by funds: $11K → $1K (-$10K)

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
3
Calls
$14K
Puts
Net Calls
+$14K
Net Calls Change
+$14K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$29.1K
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
1
Creative Planning
Kansas
$1K
SM
2
Sabby Management
Florida
-$29.1K -1,028,634 Closed

CYTXW Hedge Fund Activity: Q1 2018 in Review

2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q1 2018, worth a combined $1K — down 91% from $11K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CYTXW and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $29.1K sold.

  • 2 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q1 2018, down from 4 in Q4 2017.
  • Funds reported $1K of Cytori Therapeutics Inc Warrant stock for Q1 2018, down 91% quarter-over-quarter.
  • 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q1 2018 and 3 closed out, a net change of -2 holders.
  • The largest Cytori Therapeutics Inc Warrant seller in Q1 2018 was Sabby Management, an estimated $29.1K sold.

Based on aggregated 13F filings for Q1 2018.